BRCA1/BRCA2: CanVIG-UK Gene-Specific Guidance
For use in conjunction with CanVIG-UK Consensus Specification for Cancer susceptibility Genes of ACGSBest Practice Guidelines for Variant Classification. Evidence lines for which there are no gene-specificrecommendations should be reviewed in context of CanVIG-UK Consensus Specification for CancerSusceptibility Genes.
Institutions
- Belfast Health and Social Care Trust (GB)
- Cardiff and Vale University Health Board (GB)
- North Bristol NHS Trust (GB)
- Royal Marsden NHS Foundation Trust (GB)
- Nottingham University Hospitals NHS Trust (GB)
- University of Ulster (GB)
- Institute of Cancer Research (GB)
- University of Exeter (GB)
- Leeds Teaching Hospitals NHS Trust (GB)
- Royal Devon & Exeter NHS Foundation Trust (GB)
- Western General Hospital (GB)
- NHS Greater Glasgow and Clyde (GB)
- Great Ormond Street Hospital for Children NHS Foundation Trust (GB)
- University Hospital of Wales (GB)
- St George’s University Hospitals NHS Foundation Trust (GB)
- Southmead Hospital (GB)
- University Hospital Southampton NHS Foundation Trust (GB)
- University of Manchester (GB)
- Children's Health Ireland at Crumlin (IE)
- Sheffield Children's NHS Foundation Trust (GB)
- Royal Victoria Hospital (GB)
- Genomics England (GB)
- Birmingham Women’s and Children’s NHS Foundation Trust (GB)
- Queen Elizabeth University Hospital (GB)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-02-05
- DOI
- https://doi.org/10.5281/zenodo.14974379
- Primary Topic
- BRCA gene mutations in cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00